NCT07740174

Brief Summary

This study aims to evaluate the efficacy of seated exercise on functional capacity and quality of life in patients with leukemia during chemotherapy cycles Participants will receive efficacy of seated exercise on functional capacity and quality of life in patients with leukemia during chemotherapy cycles over a defined period. Outcomes will be assessed using Pulmonary function test, 6 min walk test and FACT- G questionnaire to determine improvements in quality of life in cancer patient rehabilitation special to diagnosed with leukemia.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable leukemia

Timeline
4mo left

Started Aug 2026

Shorter than P25 for not_applicable leukemia

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 28, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

seated exercise, Functional capacity, Quality of life, Chemotherapy, Exercise therapy

Outcome Measures

Primary Outcomes (2)

  • change in functional capacity

    Functional capacity will be assessed by the six-minute walk test (6MWT) distance before and after the four week seated exercise programe.

    Baseline and after 4 weeks of intervention

  • change in quality of life

    Quality of life will be assessed using the FACT-G questionnaire before and after the four week seated exercise programe

    Baseline and after 4 weeks of intervention

Secondary Outcomes (1)

  • Change in Maximum Voluntary Ventilation (MVV)

    Baseline and after 4 weeks of intervention

Study Arms (2)

Seated exercise group

EXPERIMENTAL
Behavioral: Seated exercise

control group

NO INTERVENTION

Interventions

Seated exerciseBEHAVIORAL

Participants in the intervention group will perform a structured seated exercise program during their chemotherapy cycles. The exercise program will consist of supervised, individualized seated exercises designed to improve functional capacity and quality of life. The exercise sessions will be performed according to the study protocol throughout the intervention period. Each session will consist of a five-minute warm up, 20 minutes of moderate intensity repetitive motion exercises, and a five -minute cool-down. Functional outcomes will be assessed before and after the exercise program. including maximum voluntary ventilation , six-minute walk test distance, and FACT- G quesionnaire.

Seated exercise group

Eligibility Criteria

Age30 Years - 40 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male patients with age ranges from 30 to 40 years.
  • All patients in this study will be on chemotherapy from at least one cycle as a treatment of leukemia.
  • All patients will be hemodynamically stable.
  • Patients are ambulant.

You may not qualify if:

  • Lung cancer
  • History of any pulmonary disease.
  • Metastasis of lung , ribs and mediastinal structure.
  • Pulmonary pathology (e.g. acute respiratory distress syndrome, or exacerbation of chronic obstructive pulmonary disease).
  • Ruptured eardrum or any other condition of the ear.
  • Severe bronchospasm.
  • High peak air way pressure (barotraumas).
  • patients with marked elevated left ventricular end- diastolic volume and pressure.
  • patients with worsening haert failure signs and symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Leukemia

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy for general surgery, Burn and skin, Suez university, Suez ,Egypt

Study Record Dates

First Submitted

July 28, 2026

First Posted

July 31, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 31, 2026

Record last verified: 2026-07